Briana Anderson - Cornell University
Briana Anderson - Cornell University
Briana Anderson - Cornell University
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
55<br />
H3: In a high involvement condition, people will rely less on the physical appearance<br />
of endorser when making judgments about organizational credibility than in a low<br />
involvement condition. Thus, higher levels of personal involvement will result in a<br />
smaller difference in means of endorser credibility between attractive and unattractive<br />
endorsers.<br />
Hypothesis 3 deals with the role of cognitive involvement in perceptions of<br />
endorser credibility. H3 was not supported by this test. Tables 26 and 27 present the<br />
findings of the univariate ANOVA model with attractiveness, company type, and<br />
personal involvement as the fixed factors. Table 26 presents the results from the<br />
univariate ANOVA, which shows a main effect for attractiveness (unattractive<br />
received higher endorser credibility ratings) and for personal involvement. Figures 7<br />
and 8 on page 58 highlight the fact that the difference in means was actually greater<br />
for those with high involvement than those with low involvement (the opposite of the<br />
hypothesis). This finding suggests that those with high involvement made stronger<br />
judgments based on attractiveness than those with low involvement. Additionally,<br />
Table 26 illustrates that those respondents with a higher level of cognitive<br />
involvement had higher overall ratings of endorser credibility (see Table 27 for the<br />
means).<br />
An interesting finding in this series of univariate ANOVA models is that for<br />
the models where endorser trustworthiness and expertise were the dependent variable,<br />
company type became a significant main effect variable when the endorsers (both<br />
attractive and unattractive) paired with the cosmetic company got higher ratings of<br />
endorser trustworthiness and expertise than that of the endorsers with the<br />
pharmaceutical company.